Fact Source: Financial Supervisory Service DART
Market: KOSPI (000660)
💡 3-Second Summary
SK Hynix has decided to issue overseas Depositary Receipts (DRs) based on newly issued common shares for listing on the U.S. Nasdaq, raising KRW 45.45T in facility capital.
📊 [Key Summary & Financial Figures]
- Company Name: SK Hynix Inc.
- DR Issuance Type: New Share DR (Third-Party Allocation)
- Total DR Issuance Amount: KRW 45,453,450,000,000 (approx. KRW 45.45T)
- New Share Issue Price: KRW 2,555,000 per common share (Reference figure based on closing price on the day prior to Board resolution)
- Issue Price per DR: KRW 255,500
- Underlying Share Conversion Ratio per DR: 0.1 shares (1 Share : 10 DRs)
- Issuance Country: Overseas Market (United States)
- Purpose of Financing: Facility Capital KRW 45,453,450,000,000
- (1) Yongin Semiconductor Cluster Phase 1 Fab construction investment
- (2) Cheongju P&T7 Advanced Packaging Fab construction/equipment/incidental expenses
- (3) EUV Scanner machinery acquisition and facility investment
- Subscription & Payment Date: July 14, 2026
- Listing Exchange & Expected Date: Nasdaq Global Select Market (Scheduled for July 10, 2026)
- Expected Listing Date of Underlying New Shares: July 29, 2026
- Lead Underwriters: BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs (Asia) L.L.C., J.P. Morgan Securities LLC
- Custodian / Overseas Depositary: Korea Securities Depository / Citibank, N.A.
- Board Resolution Date: June 24, 2026 (6 outside directors present, 0 absent)
- Other Key Decision Details:
- Final disclosure resolving previous inquiry disclosure requests regarding U.S. listing reports.
- Total issuance amount and issue price are reference figures based on the maximum limit (17,790,000 shares) and closing price; final figures will be confirmed after overseas institutional bookbuilding and submitted via amended disclosures.
- Schedules including subscription, payment, and listing dates are subject to change depending on bookbuilding results.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying Final DR Issue Price and Confirmed Financing Amount Post-Bookbuilding
This disclosure announces the Board’s decision to issue American Depositary Receipts (ADRs) based on new shares for listing on the U.S. Nasdaq market. Because the disclosed total amount and issue price are maximum reference figures based on the closing stock price, tracking the final issue price, actual capital raised, and finalized listing dates determined through overseas institutional bookbuilding is important to accurately understand the transaction structure and financial impact. Related final details can be verified in future correction disclosures, registration statements, and subsequent periodic reports (Quarterly, Half-Year, or Annual Reports).
📢 Disclaimer and Source Notice
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s DART system.
Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
